The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects
- 3 April 2020
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 507, 125-131
- https://doi.org/10.1016/j.cca.2020.03.044
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Is MSAFP Still a Useful Test for Detecting Open Neural Tube Defects and Ventral Wall Defects in the Era of First-Trimester and Early Second-Trimester Fetal Anatomical Ultrasounds?Fetal Diagnosis and Therapy, 2014
- Assessing the prevalence of spina bifida and encephalocele in a Kenyan hospital from 2005–2010: implications for a neural tube defects surveillance systemPan African Medical Journal, 2014
- Screening for fetal aneuploidy and neural tube defectsGenetics in Medicine, 2009
- Controversies in the management of germ cell tumours of the ovaryCurrent Opinion in Oncology, 2006
- Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratioCongenital Anomalies, 2004
- Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down’s syndromeClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Model‐based screening by risk with application to down's syndromeStatistics in Medicine, 1992
- Lectin Reactivity of Alpha-Fetoprotein in a Case of Renal Cell CarcinomaTumor Biology, 1989
- Improved Diagnosis of Neural Tube Defects: Measurement of Concanavalin A-Reactive Variants of AFP in Amniotic FluidAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1981